Presurgical (neoadjuvant) endocrine therapy is a useful model to predict response and outcome to endocrine treatment in breast cancer patients
Jürgen Geisler, Ian Smith, William MillerVolume:
131
Year:
2012
Language:
english
DOI:
10.1016/j.jsbmb.2011.12.006
File:
PDF, 740 KB
english, 2012